Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

REVERSIBLE DEMENTIA TEMPORALLY ASSOCIATED WITH INTRAVENTRICULAR THERAPY WITH METHOTREXATE IN A CHILD WITH ACUTE MYELOGENOUS LEUKEMIA JOURNAL OF PEDIATRICS Pizzo, P. A., Bleyer, W. A., POPLACK, D. G., Leventhal, B. G. 1976; 88 (1): 131-133

Abstract

During maintenance therapy with intraventricular methotrexate, progressive dementia developed in a child with meningeal leukemia. Cerebrospinal fluid levels of MTX were in the nontoxic range and neurologic evaluation failed to demonstrate anatomic obstruction, infection, or folate depletion. The patient's symptoms gradually resolved when the methotrexate was discontinued, suggesting that methotrexate neurotoxicity may occur in the absence of an elevated CSF concentration of MTX.

View details for Web of Science ID A1976BB30900026

View details for PubMedID 1060745